Welgus Howard G.

Director | Chief Medical Officer

1 company

Good

Trades Analyzed

12M Win Rate

60.6%

Avg 3M Return

-2.0%

Avg 12M Return

-2.4%

Welgus Howard G. is a Director at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 14 sells.

Estimated insider holdings value: $989K based on current market prices.

Holdings by Company

ARQT5d ago

Current Shares37.7K

Value$989.2K

Net Activity-313,981

Bought: 0Sold: 314.0K

Showing 10 filings (page 4)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 2, 2022	ARQT Arcutis Biotherapeutics, Inc.	Director	Sale+OE	2,500	$20.44	$51,112.00	-1.4%	-5.1%	-33.4%
Apr 1, 2022	ARQT Arcutis Biotherapeutics, Inc.	Director	Sale+OE	7,500	$20.02	$150,183.75	-4.0%	+4.8%	-45.9%
Jan 3, 2022	ARQT Arcutis Biotherapeutics, Inc.	Director	Sale+OE	2,500	$21.21	$53,029.50	-1.4%	-6.3%	-35.2%
Dec 23, 2021	ARQT Arcutis Biotherapeutics, Inc.	Director	Sale+OE	2,500	$20.16	$50,395.50	-1.4%	-12.5%	-28.9%
Nov 1, 2021	ARQT Arcutis Biotherapeutics, Inc.	Director	Sale+OE	2,500	$21.81	$54,524.00	-1.4%	-33.9%	-20.3%
Oct 1, 2021	ARQT Arcutis Biotherapeutics, Inc.	Director	Sale+OE	2,500	$23.87	$59,679.75	-1.4%	-18.8%	-24.2%
Sep 1, 2021	ARQT Arcutis Biotherapeutics, Inc.	Director	Sale+OE	5,000	$20.80	$103,986.46	-1.4%	-22.1%	+26.3%
Jul 1, 2021	ARQT Arcutis Biotherapeutics, Inc.	Director	Sale+OE	2,200	$26.13	$57,475.83	-0.6%	-14.7%	-18.0%
Jun 1, 2021	ARQT Arcutis Biotherapeutics, Inc.	Director	Sale+OE	2,200	$27.09	$59,602.71	-0.5%	-23.2%	-26.0%
May 3, 2021	ARQT Arcutis Biotherapeutics, Inc.	Director	Sale+OE	2,200	$34.79	$76,547.39	-0.5%	-33.0%	-38.1%